A Survivorship Care Plan and Embedded Navigation Tool

Inclusion Criteria

• •Histologically confirmed diagnosis of prostate adenocarcinoma
• •Age ≥18 years
• •Receiving curative intent radiotherapy for prostate cancer (Note: post-operative radiotherapy \[i.e., "adjuvant" or "salvage radiotherapy subsequent to prostatectomy\] is allowed.)
• •Subjects will be enrolled within two weeks prior to and two weeks after the final fraction of radiotherapy.
• •Receiving androgen deprivation therapy (ADT) for a duration of ≥3 consecutive months as follows:
• •* GnRH agonist or antagonist (medical castration), with or without an anti-androgen (i.e., bicalutamide, flutamide, nilutamide, etc.), OR
• •* Bilateral orchiectomy (surgical castration)
• •Technology requirement: candidates must have access to the internet
• •Able to understand and willing to sign a written informed consent document.
• •Able to speak and understand English, in the opinion of the treating physician.